Assessment of adherence to cancer-associated venous thromboembolism guideline and pharmacist’s impact on anticoagulant therapy

被引：0
|
作者：
Esin Aysel Kandemir
Aygin Bayraktar-Ekincioglu
Saadettin Kilickap
机构：
[1] Hacettepe University,Faculty of Pharmacy, Department of Clinical Pharmacy
[2] Hacettepe University,Hacettepe Cancer Institute
来源：
Supportive Care in Cancer | 2021年 / 29卷
关键词：
Cancer; Venous thromboembolism; Practice guideline; Guideline adherence; Pharmacist;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1699 / 1709
页数：10
相关论文
共 50 条
  • [41] Translation into French and republication of: "Anticoagulant treatment of cancer-associated thromboembolism"
    Mahe, I.
    Mayeur, D.
    Couturaud, F.
    Scotte, F.
    Benhamou, Y.
    Benmaziane, A.
    Bertoletti, L.
    Laporte, S.
    Girard, P.
    Mismetti, P.
    Sanchez, O.
    REVUE DE MEDECINE INTERNE, 2024, 45 (04): : 210 - 225
  • [42] An answer to "anticoagulant treatment of cancer-associated venous thromboembolism: Interpreting real-world data with caution"
    Streiff, Michael B.
    Milentijevic, Dejan
    McCrae, Keith
    Yannicelli, Daniel
    Lejeune, Dominique
    Nelson, Winnie W.
    Laliberte, Francois
    Crivera, Concetta
    Lefebvre, Patrick
    Schein, Jeff
    Khorana, Alok A.
    AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (09) : E225 - E227
  • [43] Successful Model for Guideline Implementation to Prevent Cancer-Associated Thrombosis: Venous Thromboembolism Prevention in the Ambulatory Cancer Clinic
    Holmes, Chris E.
    Ades, Steven
    Gilchrist, Susan
    Douce, Daniel
    Libby, Karen
    Rogala, Britny
    Parenteau, Emily
    Cushman, Mary
    Holm, Allison Kaigle
    JCO ONCOLOGY PRACTICE, 2020, 16 (09) : 589 - +
  • [44] Machine Learning for Prediction of Cancer-Associated Venous Thromboembolism
    Mantha, Simon
    Dunbar, Andrew
    Bolton, Kelly L.
    Devlin, Sean
    Gorenshteyn, Dmitriy
    Donoghue, Mark
    Arcila, Maria E.
    Soff, Gerald A.
    BLOOD, 2020, 136
  • [45] Cancer-associated venous Thromboembolism: Edoxaban versus Dalteparin
    Lorenz, Judith
    TRANSFUSIONSMEDIZIN, 2018, 8 (03) : 137 - 137
  • [46] Clinical controversies in the treatment of cancer-associated venous thromboembolism
    Nachar, Victoria R.
    Schepers, Allison J.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2021, 27 (04) : 939 - 953
  • [47] Cancer-Associated Venous Thromboembolism - Beyond 6 Months
    Noble, Simon
    NEW ENGLAND JOURNAL OF MEDICINE, 2025,
  • [48] Direct Oral Anticoagulants for Cancer-Associated Venous Thromboembolism
    Masini, Marta
    Toma, Matteo
    Spallarossa, Paolo
    Porto, Italo
    Ameri, Pietro
    CURRENT ONCOLOGY REPORTS, 2023, 25 (09) : 979 - 987
  • [49] Guidance for the prevention and treatment of cancer-associated venous thromboembolism
    Alok A. Khorana
    Marc Carrier
    David A. Garcia
    Agnes Y. Y. Lee
    Journal of Thrombosis and Thrombolysis, 2016, 41 : 81 - 91
  • [50] Current status of treatment of cancer-associated venous thromboembolism
    Wei Xiong
    Thrombosis Journal, 19
12345